1,457
Views
4
CrossRef citations to date
0
Altmetric
Articles

Stereoselectivity evaluation of chiral chitosan microspheres delivery system containing rac-KET in vitro and in vivo

, , , &
Pages 63-69 | Received 25 Oct 2018, Accepted 03 Dec 2018, Published online: 11 Feb 2019

References

  • Álvarez C, Torrado JJ, Cadórniga R. (1999). Stereoselective drug release from ketoprofen and ricobendazole matrix tablets. Chirality 11:611–5.
  • Asghar W, Pittman E, Jamali F. (2015). Most chiral drugs have been used as racemates while the beneficial effects are often attributed mainly to one of the enantiomers. DARU J Pharm Sci 23:50–7.
  • Barbanoj MJ, Antonijoan RM, Gich I. (2001). Clinical pharmacokinetics of dexketoprofen. Clin Pharmacokinet 40:245–62.
  • Bressolle F, Rochette A, Khier S, et al. (2009). Population pharmacokinetics of the two enantiomers of tramadol and O-demethyl tramadol after surgery in children. Brit J Anaesth 102:390–9.
  • Brocks DR. (2000). Stereoselective pharmacokinetics of desbutylhalofantrine, a metabolite of halofantrine, in the rat after administration of the racemic metabolite or parent drug. Biopharm Drug Dispos 21:365–71.
  • Duddu SP, Vakilynejad M, Jamali F, Grant DJW. (1993). Stereoselective dissolution of propranolol hydrochloride from hydroxypropylmethylcellulose matrices. Pharm Res 10:1648–53.
  • Hamdy DA, Brocks DR. (2009). Nonlinear stereoselective pharmacokinetics of ketoconazole in rat after administration of racemate. Chirality 21:704–12.
  • Jamali F, Brocks DR. (1990). Clinical pharmacokinetics of ketoprofen and its enantiomers. Clin Pharmacokinet 19:197–217.
  • Jin SP, Feng L, He WY, et al. (2010). Preparation and release behavior in vitro of aspirin/chitosan nanospheres by nucleation and ionic crosslinking in emulsion. Acta Phys Chim Sin 26:2581–8.
  • Jonathan MC, Michael JO. (2003). Stereochemistry in Drug Action. Prim Care Companion J Clin Psychiatry 5:70–3.
  • Kunz CM, Vakily M, Jamali F. (1994). Stereoselective release of racemic drugs in the presence of chiral excipients. Pharm Res S-305. AAPS Annual Meeting PDD 7521.
  • Maggi L, Massolini G, De Lorenzi E, et al. (1996). Evaluation of stereoselective dissolution of verapamil hydrochloride from matriz tablets press-coated with chiral excipients. Int J Pharm 136:43–52.
  • Majid V, Fakheddin J. (1994). Human Pharmacokinetics of tiaprofenic acid after regular and sustained release formulations: lack of chiral inversion and stereoselective release. J Pharma Sci 83:495–8.
  • Muller N, Payan E, Lapicque F, et al. (1990). Pharmacological aspects of chiral non-steroidal antiinflammatory drugs. Fund Clin Pharmacol 4:617–34.
  • Nagilla R, Deshmukh DD, Duran SH, Ravis WR. (2007). Stereoselective pharmacokinetics of ketorolac in calves after a single intravenous and oral dose. J Vet Pharmacol Ther 30:437–42.
  • Sakajiri T, Kikuchi T, Simon I, et al. (2006). Molecular dynamics approach to study the discrepancies in the thermal behavior of amylose and chitosan conformations. Theochem 764:133–40.
  • Shantha KL, Harding DRK. (2002). Synthesis and characterization of chemically modified chitosan microspheres. Carbohydr Pol 48:247–53.
  • Shen Q, Wang L, Zhou H, et al. (2013). Stereoselective binding of chiral drugs to plasma proteins. Acta Pharmacol Sin 34:998–1006.
  • Sinha VR, Singla AK, Wadhawan S, et al. (2004). Chitosan microspheres as a potential carrier for drugs. Int J Pharm 274:1–33.
  • Solinis MA, Cruz Y, Hernandez RM, et al. (2002a). Release of ketoprofen enantiomers from HPMC K100M matrices diffusion studies. Int J Pharm 239:61–8.
  • Solinis MA, Cruz Y, Calvo B, et al. (2002b). Release of salbutamol sulphate and ketoprofen enantiomers from matrices containing HPMC and cellulose derivatives. Chirality 14:806–812.
  • Solinís MA, Lugará S, Calvo B, et al. (1998). Release of salbutamol sulfate enantiomers from hydroxypropylmethylcellulose matrices. Int J Pharm 161:37–43.
  • Srichana T, Suedee R. (2001). Evaluation of stereoselective dissolution of racemic salbutamol matrices prepared with commonly used excipients and 1H-NMR study. Drug Dev Ind Pharm 27:457–64.
  • Suedee R, Brain K, Heard CM. (1997). Enantioselective retardation of rac-propranolol from matrices containing cellulose derivatives. Chirality 9:307–12.
  • Suedee R, Srichana T, Martin GP. (2000). Evaluation of matrices containing molecularly imprinted polymers in the enantioselective-controlled delivery of β-blockers. J Control Rel 66:135–47.
  • Vakily M, Pasutto FM, Daneshtalab M, Jamali F. (1995). Inclusion complexation of heptakis (2,6-di-ethyl)-b-cyclodextrin with tiaprofenic acid: pharmacokinetic consequences of a pH-dependent release and stereoselective dissolution. J Pharm Sci 84:1014–9.
  • Wang SH, Liang ZH, Zeng S. (2007a). Monitoring release of ketoprofen enantiomers from biodegradable poly (D,L-lactide-co-glycolide) injectable implants. Inter J Pharm 337:102–8.
  • Wang QX, Qiu J, Wang P, et al. (2005). Stereoselective kinetic study of hexaconazole enantiomers in the rabbit. Chirality 17:186–92.
  • Wang Q, Qiu J, Zhou Z, et al. (2009). Stereoselective pharmacokinetics of diniconazole enantiomers in rabbits. Chirality 21:699–703.
  • Wang SH, Yin LN, Liang ZH, et al. (2007b). Stereoselective behavior of a novel biodegradable racemic ketoprofen injectable Implant in rats. Chirality 19:769–74.
  • Yamada T, Onishi H, Machida Y. (2001). In vitro and in vivo evaluation of sustained release chitosan-adjuvanteded ketoprofen microspheres. Yakugaku Zasshi 121:239–45.